MedPath

Theophylline

Generic Name
Theophylline
Brand Names
Elixophyllin, Elixophylline, Pulmophylline, Quibron-T, Theo-24, Theolair, Uniphyl
Drug Type
Small Molecule
Chemical Formula
C7H8N4O2
CAS Number
58-55-9
Unique Ingredient Identifier
0I55128JYK

Overview

A methylxanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Mechanistically, theophylline acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Theophylline is marketed under several brand names such as Uniphyl and Theochron, and it is indicated mainly for asthma, bronchospasm, and COPD.

Indication

For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.

Associated Conditions

  • Asthma
  • Bronchitis
  • Bronchoconstriction
  • Bronchospasm
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic bronchial inflammation

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Chartwell RX, LLC
62135-457
ORAL
300 mg in 1 1
2/13/2023
Carilion Materials Management
68151-1393
ORAL
300 mg in 1 1
12/5/2016
Glenmark Pharmaceuticals Inc., USA
68462-721
ORAL
300 mg in 1 1
6/4/2021
State of Florida DOH Central Pharmacy
53808-0982
ORAL
300 mg in 1 1
4/24/2014
Physicians Total Care, Inc.
54868-1461
ORAL
100 mg in 1 1
9/23/2011
Golden State Medical Supply, Inc.
51407-319
ORAL
600 mg in 1 1
1/31/2024
Endo Pharmaceuticals, Inc.
52244-200
ORAL
200 mg in 1 1
8/30/2017
Amneal Pharmaceuticals NY LLC
60219-2045
ORAL
300 mg in 1 1
3/22/2023
Nostrum Laboratories, Inc.
29033-060
ORAL
450 mg in 1 1
8/15/2023
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
23155-742
ORAL
450 mg in 1 1
6/27/2022

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
NUELIN SR 250 theophylline 250mg tablet
46069
Medicine
A
8/11/1993

Health Canada Drug Approvals

View More Health Canada Approvals

Sign in to access additional Health Canada approved drug information with detailed regulatory data.

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
TEVA-THEOPHYLLINE SR
teva canada limited
02230086
Tablet (Extended-Release) - Oral
200 MG
12/19/1996
THEOPHYLLINE SUSTAINED RELEASE TAB 200MG
forest labs inc
00631701
Tablet (Extended-Release) - Oral
200 MG / TAB
12/31/1985
UNIPHYL
elvium life sciences
02014165
Tablet (Extended-Release) - Oral
400 MG
12/31/1987
THEOPHYLLINE 0.8MG/ML IN 5% DEXTROSE INJ
hospira healthcare ulc
00640093
Solution - Intravenous
0.8 MG / ML
12/31/1986
THEOPHYLLINE ELX
technilab pharma inc.
00532223
Elixir - Oral
80 MG / 15 ML
12/31/1981
AA-THEO LA
aa pharma inc
00692700
Tablet (Extended-Release) - Oral
300 MG
12/31/1993
THEOCHRON SRT 200MG
forest labs inc
00631701
Tablet (Extended-Release) - Oral
200 MG / TAB
12/31/1985
TEDRAL TAB
parke-davis division, warner-lambert canada inc.
00476846
Tablet - Oral
118 MG / TAB
12/31/1981
TEVA-THEOPHYLLINE SR
teva canada limited
02230087
Tablet (Extended-Release) - Oral
300 MG
4/16/1998
THEO ER
aa pharma inc
02360128
Tablet (Extended-Release) - Oral
600 MG
6/23/2011

CIMA AEMPS Drug Approvals

View More CIMA AEMPS Approvals

Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

View More Philippines FDA Approvals

Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

View More Saudi SFDA Approvals

Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

View More Malaysia NPRA Approvals

Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

View More UK EMC Drug Information

Sign in to access additional UK EMC drug information with detailed pharmaceutical data.

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.